Compare VCEL & TIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VCEL | TIC |
|---|---|---|
| Founded | 1989 | 1991 |
| Country | United States | United States |
| Employees | N/A | 12760 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | 1996 | N/A |
| Metric | VCEL | TIC |
|---|---|---|
| Price | $36.30 | $8.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $57.75 | $11.20 |
| AVG Volume (30 Days) | 588.4K | ★ 2.0M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $276,259,000.00 | N/A |
| Revenue This Year | $19.40 | $44.09 |
| Revenue Next Year | $18.24 | $4.40 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 16.45 | N/A |
| 52 Week Low | $28.95 | $6.36 |
| 52 Week High | $45.97 | $14.94 |
| Indicator | VCEL | TIC |
|---|---|---|
| Relative Strength Index (RSI) | 58.19 | 43.48 |
| Support Level | $35.85 | $6.55 |
| Resistance Level | $38.31 | $10.66 |
| Average True Range (ATR) | 1.57 | 0.48 |
| MACD | 0.16 | -0.06 |
| Stochastic Oscillator | 81.12 | 33.07 |
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
TIC Solutions Inc is a provider of tech-enabled Testing, Inspection, Certification and Compliance (TICC), engineering, and geospatial services. It provides mission-critical services that are essential to the safety, reliability, and efficiency of industrial assets, buildings and public infrastructure. The company's services are often non-discretionary and are driven by regulatory requirements, customer risk management policies, and the need to extend the useful life of critical assets. It operates in North America and serve both public- and private-sector clients. Its public-sector clients include federal, state, and municipal agencies, public utilities, and environmental regulators. Its private-sector clients span industrial, infrastructure, construction, and real estate end markets.